Latest
News
Check out the latest news and announcements from Hippo T&C
Notice July 2, 2024
Hippo T&C Meets with UNMC Psychiatry Professors to Discuss Collaboration
#UNMC#Hippo T&C#Collaboration
Read More Press Release June 27, 2024
Hippo T&C and 15 Other Companies Named '2024 Global ICT Future Unicorns'
#2024 Global ICT Future Unicorns#The Ministry of Science and ICT
Read More Press Release June 18, 2024
Hippo T&C Selected for NIPA’s ‘AI-Based Public Healthcare Institution Digital Transformation Project’
#Public Healthcare Project#NIPA
Read More Press Release September 26, 2023
“Digital Healthcare Forum 2023” Opens on the 25th at COEX A Hall with a Large Delegation from Denmark
#DHF2023#Digital Healthcare Forum#Exhibition
Read More Press Release September 1, 2023
[IFA 2023] K-Small and Medium Enterprises and Startups Forge Global Expansion Gateway Beyond Europe
#IFA2023#Exhibition#AttnKare
Read More Notice September 1, 2023
AttnKare-D by Hippo T&C on Display at Seongnam GXG 2023
#GXG2023#AttnKare#Exhibition
Read More Press Release July 28, 2023
Psychiatry secures research funding from South Korea
#UNMC#Funding#Clinical Trial
Read More Notice June 21, 2023
AttnKare-D to Conduct Clinical Trials with the University of Nebraska Medical Center in the U.S.
#Clinical Trial#UNMC#AttnKare
Read More Press Release April 6, 2023
Tai-Myoung Chung, CEO of Hippo T&C, stated, "We are establishing a U.S. corporation and intensifying our efforts to penetrate the North American market! "
#Tai-Myoung Chung#Interview
Read More Notice April 3, 2023
Hippo T&C Unveils Three Self-Developed Digital Therapeutic Devices
#Hippo T&C Showcase
Read More Notice January 23, 2023
Hippo T&C Showcases Three Products at APSARD
#APSARD2023#AttnKare#BlueKare
Read More Press Release January 18, 2023
[Issue] Treating Illness with Digital Therapeutics Instead of Medications... Consumer Commercialization Approaches
#DTx#AttnKare#BlueKare
Read More